公开(公告)号：WO2007076035A3

公开(公告)日：2007-07-05

申请号：PCT/US2006/049080

申请日：2006-12-20

Applicant: ABBOTT LABORATORIES ,  ROCKWAY, Todd, W. ,  BETEBENNER, David, A. ,  KRUEGER, Allan, C. ,  IWASAKI, Nobuhiko ,  COOPER, Curt, S. ,  ANDERSON, David, D. ,  KEMPF, Dale, J. ,  MADIGAN, Darold, L. ,  MOTTER, Christopher, E. ,  SHANLEY, Jason, P. ,  TUFANO, Michael, D. ,  WAGNER, Rolf ,  ZHANG, Rong ,  MOLLA, Akhteruzzaman ,  MO, Hongmei ,  PILOT-MATIAS, Tami ,  MASSE, Sherie, VL. ,  CARRICK, Robert, J. ,  HE, Weping ,  LU, Liangjun

Inventor： ROCKWAY, Todd, W. ,  BETEBENNER, David, A. ,  KRUEGER, Allan, C. ,  IWASAKI, Nobuhiko ,  COOPER, Curt, S. ,  ANDERSON, David, D. ,  KEMPF, Dale, J. ,  MADIGAN, Darold, L. ,  MOTTER, Christopher, E. ,  SHANLEY, Jason, P. ,  TUFANO, Michael, D. ,  WAGNER, Rolf ,  ZHANG, Rong ,  MOLLA, Akhteruzzaman ,  MO, Hongmei ,  PILOT-MATIAS, Tami ,  MASSE, Sherie, VL. ,  CARRICK, Robert, J. ,  HE, Weping ,  LU, Liangjun

IPC: C07D471/04

Abstract: Compounds effective in inhibiting replication of Hepatitis C virus ("HCV") or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, co-formulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and intermediates for the syntheses of such compounds, and methods of using such compounds for the treatment of HCV or other viral infections.

公开(公告)号：EP1979349A2

公开(公告)日：2008-10-15

申请号：EP06848056.5

申请日：2006-12-20

Applicant: ABBOTT LABORATORIES

Inventor： ROCKWAY, Todd W. ,  BETEBENNER, David A. ,  KRUEGER, Allan C. ,  IWASAKI, Nobuhiko ,  COOPER, Curt S. ,  ANDERSON, David D. ,  KEMPF, Dale J. ,  MADIGAN, Darold L. ,  MOTTER, Christopher E. ,  SHANLEY, Jason P. ,  TUFANO, Michael D. ,  WAGNER, Rolf ,  ZHANG, Rong ,  MOLLA, Akhteruzzaman ,  MO, Hongmei ,  PILOT-MATIAS, Tami ,  MASSE, Sherie VL. ,  CARRICK, Robert J. ,  HE, Weping ,  LU, Liangjun

IPC: C07D471/04

CPC classification number: C07D471/04

Abstract: Compounds effective in inhibiting replication of Hepatitis C virus ('HCV') or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, co-formulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and intermediates for the syntheses of such compounds, and methods of using such compounds for the treatment of HCV or other viral infections.

公开(公告)号：EP1979349B1

公开(公告)日：2010-07-28

申请号：EP06848056.5

申请日：2006-12-20

Applicant: ABBOTT LABORATORIES

Inventor： ROCKWAY, Todd W. ,  BETEBENNER, David A. ,  KRUEGER, Allan C. ,  IWASAKI, Nobuhiko ,  COOPER, Curt S. ,  ANDERSON, David D. ,  KEMPF, Dale J. ,  MADIGAN, Darold L. ,  MOTTER, Christopher E. ,  SHANLEY, Jason P. ,  TUFANO, Michael D. ,  WAGNER, Rolf ,  ZHANG, Rong ,  MOLLA, Akhteruzzaman ,  MO, Hongmei ,  PILOT-MATIAS, Tami ,  MASSE, Sherie VL. ,  CARRICK, Robert J. ,  HE, Weping ,  LU, Liangjun

IPC: C07D471/04

CPC classification number: C07D471/04

Abstract: Compounds effective in inhibiting replication of Hepatitis C virus ('HCV') or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, co-formulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and intermediates for the syntheses of such compounds, and methods of using such compounds for the treatment of HCV or other viral infections.